pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
(atezolizumab + hyaluronidase (human recombinant))
Tecentriq Hybreza ((atezolizumab + hyaluronidase-tqjs (human recombinant)))
Hepatocellular Carcinoma
Genentech Inc
5 catalysts
Marketed
(hyaluronidase (recombinant, human) + nivolumab)
Opdivo Qvantig ((hyaluronidase-nvhy (recombinant, human) + nivolumab))
Adenocarcinoma Of The Gastroesophageal Junction
Bristol-Myers Squibb Co
5 catalysts
Marketed
CLADRIBINE
CLADRIBINE (CLADRIBINE)
Relapsing Remitting Multiple Sclerosis (RRMS)
EMD Serono Inc
1 catalysts
← prev
page 5 of 62
next →
131
Pain89
Neurology1
Marketed
enfortumab vedotin
Padcev (enfortumab vedotin-ejfv)
Muscle Invasive Bladder Cancer (MIBC)
Nectin-4Tubulin
Astellas Pharma Inc
12 catalysts
Marketed
FULVESTRANT
FULVESTRANT (FULVESTRANT)
Hormone Sensitive Breast Cancer
Eagle Pharmaceuticals Inc
4 catalysts
Marketed
cosibelimab
Unloxcyt (cosibelimab-ipdl)
Cutaneous Squamous Cell Carcinoma (cSCC)
Checkpoint Therapeutics Inc
2 catalysts
Marketed
selpercatinib
Retevmo (selpercatinib)
Anaplastic Thyroid Cancer
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RETProto-oncogene tyrosine-protein kinase receptor Ret
Eli Lilly and Co
19 catalysts
Marketed
tarlatamab
Imdelltra (tarlatamab-dlle)
Small-Cell Lung Cancer
$AMGNAMGEN INC
2 catalysts
Marketed
sevabertinib
Hyrnuo (sevabertinib)
Non-Small Cell Lung Cancer
Bayer AG
1 catalysts
Marketed
alitretinoin
Panretin (alitretinoin)
Kaposi Sarcoma
Galephar Pharmaceutical Research Inc
5 catalysts
Marketed
pertuzumab biosimilar
Poherdy (pertuzumab-dpzb)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
EirGenix Inc
1 catalysts
Marketed
tisotumab vedotin
Tivdak (tisotumab vedotin-tftv)
Bladder Cancer
Tissue factorTubulin
Genmab AS
4 catalysts
Marketed
amivantamab
Rybrevant (amivantamab-vmjw)
Non-Small Cell Lung Cancer
Janssen Biotech Inc
11 catalysts
Marketed
lazertinib mesylate
Lazcluze (lazertinib mesylate)
Non-Small Cell Lung Cancer
Epidermal growth factor receptor
$JNJJOHNSON & JOHNSON
3 catalysts
Marketed
NELARABINE
NELARABINE (NELARABINE)
$AMRXAmneal Pharmaceuticals, Inc.
2 catalysts
Marketed
methylprednisolone sodium succinate
Methylprednisolone Sodium Succinate (methylprednisolone sodium succinate)
Drug Hypersensitivity Reactions
Sagent Pharmaceuticals Inc
48 catalysts
Marketed
pentostatin
Pentostatin (pentostatin)
Hairy Cell Leukemia
Hikma Pharmaceuticals USA Inc
12 catalysts
Marketed
axitinib SR
AXPAXLI (axitinib)
Wet (Neovascular / Exudative) Macular Degeneration
Vascular endothelial growth factor receptor
$OCULOCULAR THERAPEUTIX, INC
1 catalysts
Marketed
denosumab biosimilar
Jubereq (denosumab-dssb)
Post Menopausal Osteoporosis
Luye Pharma Group Ltd
2 catalysts
Marketed
glofitamab
Columvi (glofitamab-gxbm)
Mantle Cell Lymphoma
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
F. Hoffmann-La Roche Ltd
3 catalysts
Marketed
LOMUSTINE
LOMUSTINE (LOMUSTINE)
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Carnegie Pharmaceuticals LLC
1 catalysts
Marketed
ANASTROZOLE
ANASTROZOLE (ANASTROZOLE)
Hormone Sensitive Breast Cancer
Stason Pharmaceuticals Inc
11 catalysts
Marketed
revumenib citrate
Revuforj (revumenib citrate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$SNDXSyndax Pharmaceuticals Inc
2 catalysts
Marketed
belantamab mafodotin
Blenrep (belantamab mafodotin-blmf)
Refractory Multiple Myeloma
GlaxoSmithKline LLC
1 catalysts
Marketed
erdafitinib
Balversa (erdafitinib)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Fibroblast growth factor receptor
$JNJJOHNSON & JOHNSON
11 catalysts
Marketed
futibatinib
Lytgobi (futibatinib)
Bile Duct Cancer (Cholangiocarcinoma)
Fibroblast growth factor receptor
Taiho Oncology Inc
3 catalysts
Marketed
relugolix
Orgovyx (relugolix)
Prostate Cancer
Sumitomo Pharma America Inc
4 catalysts
Marketed
EXEMESTANE
EXEMESTANE (EXEMESTANE)
Metastatic Breast Cancer
$PFEPFIZER INC
8 catalysts
Marketed
LETROZOLE
LETROZOLE (LETROZOLE)
Breast Cancer
Yiling Pharmaceutical Ltd
9 catalysts
Marketed
IFOSFAMIDE
IFOSFAMIDE (IFOSFAMIDE)
Germinomatous (Seminomatous) Germ Cell Tumors
Baxter Healthcare Corp
4 catalysts